首页 | 本学科首页   官方微博 | 高级检索  
检索        


Development and application of a urodilatin (CDD/ANP-95#x2013;126)-specific radioimmunoassay
Authors:Christian Drummer  Fritz Fiedler  Achim Bub  Dagmar Kleefeld  Eve Dimitriades  Rupert Gerzer  Wolf-Georg Forssmann
Institution:(1) Medizinische Klinik, Klinikum Innenstadt der Universität, Ziemssenstrasse 1, W-8000 München 2, Germany;(2) Niedersächsisches Institut für Peptid-Forschung (IPF), Feodor-Lynen-Strasse 31, W-3000 Hannover 61, Germany;(3) Institut für Flugmedizin, Deutsche Forschungsanstalt für Luft- und Raumfahrt (DLR), Linder Höhe, W-5000 Köln 90, Germany
Abstract:Urodilatin, a renal natriuretic peptide that is an analogue to circulating atrial natriuretic peptide agr-ANP (99-126)], is measurable with a highly specific and sensitive radioimmunoassay. While most ANP antibodies cannot distinguish between urodilatin and other ANP analogues, the polyclonal urodilatin antibody specifically measures human urodilatin without any cross-reactivity to other ANP analogues. Urodilatin is not detected in blood from healthy volunteers nor from cardiac patients. Urinary urodilatin accounts for only a part of total urinary ANP immunoreactivity. Urodilatin excretion closely parallels sodium excretion in response to an acute volume load while changes in urinary immunoreactive ANP excretion do not reflect this renal response. We conclude that specific urodilatin assays are required to explore further the physiological role of the renal natriuretic peptide.
Keywords:Atrial natriuretic peptide  Kidney  Renal natriuretic peptide  Sodium excretion  Urodilatin
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号